Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-11. (Q32045005)

5 July 2017

title

Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-11. (English)

1 reference

5 July 2017

1 reference

Feinglass S

1

1 reference

5 July 2017

Deodhar A

series ordinal

2

1 reference

5 July 2017

publication date

1 January 2001

1 reference

5 July 2017

published in

Arthritis & Rheumatology

1 reference

5 July 2017

volume

44

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

170-175

1 reference

Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

The Role of Splenectomy in the Treatment of Thrombocytopenic Purpura Due to Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus: the response to splenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

Effect of interleukin 11 on normal and pathological thrombopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

Treatment of severe thrombocytopenia in systemic lupus erythematosus with intravenous gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

Danazol for the Treatment of Refractory Autoimmune Thrombocytopenia in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200101%2944%3A1%3C170%3A%3AAID-ANR22%3E3.0.CO%3B2-T

10.1002/1529-0131(200101)44:1<170::AID-ANR22>3.0.CO;2-T

21 January 2018

Identifiers

DOI

1 reference

release_rimc4yhiv5hkjmqlnx4zpjah5a

5 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rimc4yhiv5hkjmqlnx4zpjah5a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference